Journal of Analytical Toxicology 2000-10-01

Cocaine and its major metabolites in plasma and urine samples from patients in an urban emergency medicine setting.

R H Williams, J A Maggiore, S M Shah, T B Erickson, A Negrusz

Index: J. Anal. Toxicol. 24(7) , 478-81, (2000)

Full Text: HTML

Abstract

In this retrospective study, we examined the levels of cocaine and its major metabolites in plasma and urine from 29 randomly selected emergency department patients (19 males and 10 females, aged 19 to 55) whose urine screened positive for benzoylecgonine using fluorescence polarization immunoassay. Levels of cocaine along with benzoylecgonine, ecgonine methyl ester, and norcocaine were quantitated in EDTA plasma and urine from each patient using gas chromatography-mass spectrometry with selected ion monitoring. Admission diagnosis and history were also obtained for each patient. In plasma, the levels were 16-130 ng/mL for cocaine (n = 3), 27-96 ng/mL for ecgonine methyl ester (n = 9), and 18-1390 ng/mL for benzoylecgonine (n = 22). Norcocaine was not detected in any of the plasma samples. In urine, the concentration ranges were 4-40,130 ng/mL for cocaine (n = 23), 36-660,500 ng/mL for ecgonine methyl ester (n = 27), and 9-2520 ng/mL for norcocaine (n = 9). All urine samples were positive for benzoylecgonine (106-3,361,000 ng/mL), and benzoylecgonine was the only metabolite present in two urine samples (at concentrations of 407 and 435 ng/mL). Two patients had plasma and urine samples positive for all analytes (except norcocaine in plasma). The patient with the highest urinary concentrations of cocaine (40,130 ng/mL), ecgonine methyl ester (660,500 ng/mL), benzoylecgonine (3,361,000 ng/mL), and norcocaine (2520 ng/mL) had a small quantity of benzoylecgonine (465 ng/mL) in plasma. No correlation was noted with patient history, admitting diagnosis or symptomatology, or plasma/urine levels of cocaine or any of its metabolites.


Related Compounds

Related Articles:

Sensitive method for detection of cocaine and associated analytes by liquid chromatography-tandem mass spectrometry in urine.

2009-10-01

[J. Anal. Toxicol. 33(8) , 447-55, (2009)]

Application of discriminant analysis to differentiate between incorporation of cocaine and its congeners into hair and contamination.

2008-03-21

[Forensic Sci. Int. 176(1) , 13-8, (2008)]

Quantitation of cocaine, benzoylecgonine, cocaethylene, methylecgonine, and norcocaine in human hair by positive ion chemical ionization (PICI) gas chromatography-tandem mass spectrometry.

2000-10-01

[J. Anal. Toxicol. 24(7) , 489-95, (2000)]

Development and validation of a gas chromatography/ion trap-mass spectrometry method for simultaneous quantification of cocaine and its metabolites benzoylecgonine and norcocaine: application to the study of cocaine metabolism in human primary cultured renal cells.

2010-11-15

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 878(30) , 3083-8, (2010)]

The ability of bacterial cocaine esterase to hydrolyze cocaine metabolites and their simultaneous quantification using high-performance liquid chromatography-tandem mass spectrometry.

2011-12-01

[Mol. Pharmacol. 80(6) , 1119-27, (2011)]

More Articles...